Showing 1 - 20 results of 738 for search '(( 59 ((a decrease) OR (_ decrease)) ) OR ((( 10 we decrease ) OR ( _ pd decrease ))))*', query time: 0.22s Refine Results
  1. 1
  2. 2
  3. 3

    Antiferromagnetism in EuPdGe3 by Albedah, M.A.

    Published 2014
    “…The results of X-ray diffraction, magnetic susceptibility and magnetization, and 151Eu Mössbauer spectroscopy measurements of polycrystalline EuPdGe3 are reported. EuPdGe3 crystallizes in the BaNiSn3-type tetragonal structure (space group I4mm) with the lattice constants a=4.4457(1)Å and c=10.1703(2)Å. …”
    Get full text
    Get full text
  4. 4
  5. 5

    Quantification of the growth suppression of HER2+ breast cancer colonies under the effect of trastuzumab and PD-1/PD-L1 inhibitor. by Padmanabhan, Regina

    Published 2022
    “…Nevertheless, further studies are imperative to substantiate this argument and to uncover the potential crosstalk between PD-1/PD-L1 inhibitors and HER2 growth signaling pathways in breast cancer.…”
    Get full text
    Get full text
  6. 6

    Mycoplasma bovis-induced inhibition of bovine peripheral blood mononuclear cell proliferation is ameliorated after blocking the immune-inhibitory programmed death 1 receptor by Suleman M.

    Published 2018
    “…We demonstrated that M. bovis infection induced a significant decrease in CD4+ PD-1INT and CD8+ PD-1INT subsets with intermediate PD-1 expression, which functioned as progenitor pools giving rise to CD4+ PD-1HIGH and CD8+ PD-1HIGH subsets with high PD-1 expression levels. …”
    Get full text
    Get full text
  7. 7
  8. 8
  9. 9

    Molecular and Peritoneal Microvascular Changes Cause Peritoneal Membrane Dysfunction by Uremia-Related Mechanisms by Zakaria, El-Rasheid

    Published 2016
    “…These changes were assumed to be the cause for peritoneal membrane dysfunction and technique failure that was observed in some long-term PD patients. However, this assumption was refuted by the findings from animal models of chronic PD that showed the exact structural phenotype of the long-term PD, and yet a normal peritoneal function. …”
    Get full text
    Get full text
  10. 10
  11. 11
  12. 12
  13. 13
  14. 14
  15. 15

    Modification of Pd/CeO2 catalyst by Atomic Layer Deposition of ZrO2 by Onn, Tzia Ming

    Published 2016
    “…Calcination of the unmodified Pd/CeO2, prepared by precipitation of aqueous Ce(NO3)3 solutions, with Pd added by impregnation, caused a large decrease in surface area and an increase in crystallite size between 673 K and 1073 K; however, catalysts modified by 0.4 nm ZrO2 films showed no change in either surface area or CeO2 crystallite size upon calcination to 1073 K. …”
    Get full text
    Get full text
  16. 16
  17. 17
  18. 18

    Quality improvement can decrease blood delivery turnaround time: Evidence from a single tertiary-care academic medical center by Hammad Y.A.

    Published 2018
    “…The transport time significantly decreased from an initial majority of > 15 mins duration, to a majority of < 15 mins transport time after the second audit; there was a 50% improvement in 30 mins response time; and the percentage of requests processed in < 10 mins were significantly higher after the second audit. …”
    Get full text
  19. 19
  20. 20

    Pd nanocrystals encapsulated in MOF-derived Ni/N-doped hollow carbon nanosheets for efficient thermal CO oxidation: unveiling the effect of porosity by Ipadeola, Adewale K.

    Published 2023
    “…Conspicuously, the T100 of Pd/Ni-MOF-HNC was lower than those of most previously reported Pd-based catalysts due to the high porosity, surface area, and electronic interaction of Pd/Ni-Nx, and Ni-metal defects, which promote the adsorption/activation of reactants (CO + O2), decrease the activation energy to 73.1 kJ mol−1 and enhance the reaction rate at the same CO conversion percentage. …”
    Get full text
    Get full text
    Get full text